Ácido linoléico conjugado e perda de peso
Palavras-chave:
ácido linoléico, composição corporal, obesidade, perda de pesoResumo
O tratamento e a prevenção da obesidade têm sido considerados uma enorme batalha para os profissionais da área de saúde. As indústrias de alimentos e de fármacos, por sua vez, têm oferecido cada vez mais uma vasta gama de novos produtos que preconizam a perda de peso. O ácido linoléico conjugado, encontrado em maiores concentrações na gordura de animais ruminantes, parece apresentar efeitos favoráveis quanto à manutenção do peso corporal. Esta revisão apresenta uma análise crítica dos dados disponíveis na literatura, que relacionam o ácido linoléico conjugado com o metabolismo energético e a composição corporal. Os estudos realizados com humanos ainda não são conclusivos, embora alguns apontem um possível aumento da lipólise e/ou redução da lipogênese, que reflete em alterações apenas na composição corporal, especialmente no tecido adiposo abdominal, mas não na perda de peso. Entretanto, as altas doses usadas nesses estudos podem implicar efeitos colaterais indesejáveis. Portanto, mais estudos são necessários para uma indicação desse ácido graxo como um agente para a melhora da composição corporal e/ou como um agente antiobesidade.
Referências
Bell S, Goodrick G. A functional food product for the management of weight. Crit Rev Food Sci Nutr. 2002; 42(2):163-78.
Institute of Medicine. National Academy of Science. Opportunities in the Nutrition and Food Sciences. Washington DC: Institute of Medicine; 1994.
Agência Nacional de Vigilância Sanitária. Diretrizes básicas para análise e comprovação de propriedades funcionais. In: Regulamento técnico. Brasília: Agência Nacional de Vigilância Sanitária; 1999. Resolução n. 18.
World Health Organization. Obesity: preventing and managing the global epidemic. Geneva: World Health Organization; 1998.
Federal Trade Comission. [homepage on the internet]. Weight-loss advertising. An analysis of current trends: a federal trade commission staff report [updated, 2002 Sep 17]. Available from: URL: http://www.ftc.gov
Pariza MW, Park Y, Cook ME. The biologically active isomers of conjugated linoleic acid. Prog Lipid Res. 2001; 40(4):283-98.
Park Y, Albright KJ, Liu W, Storkson JM, Cook ME, Pariza MW. Effect of conjugated linoleic acid on body composition in mice. Lipids. 1997; 32(8): 853-8.
West DB, Blohm FY, Truett AA, DeLany JP. Conjugated linoleic acid persistently increases total energy expenditure in AKR/J mice without increasing uncoupling protein gene expression. J Nutr. 2000; 130(10):2471-7.
DeLany JP, Blohm F, Truett AA, Scimeca JA, West DB. Conjugated linoleic acid rapidly reduces body fat content in mice without affecting energy intake. Am J Physiol. 1999; 276(4 Pt 2):R1172-9.
Park Y, Albright KJ, Storkson JM, Liu W, Cook ME, Pariza MW. Changes in body composition in mice during feeding and withdrawal of conjugated linoleic acid. Lipids. 1999; 34(3):243-8.
Tsuboyama-Kasaoka N, Takahashi M, Tanemura K, Kim HJ, Tange T, Okuyama H, et al. Conjugated linoleic acid supplementation reduces adipose tissue by apoptosis and develops lipodystrophy in mice. Diabetes. 2000; 49(9):1534-42.
West DB, Delany JP, Camet PM, Blohm F, Truett AA,Scimeca J. Effects of conjugated linoleic acid on body fat and energy metabolism in the mouse. Am J Physiol. 1998; 275(3 Pt 2):R667-72.
Azain MJ, Hausman DB, Sisk MB, Flatt WP, Jewell DE. Dietary conjugated linoleic acid reduces rat adipose tissue cell size rather than cell number. J Nutr. 2000; 130(6):1548-54.
Kelly GS. Conjugated linoleic acid: A review. Altern Med Rev. 2001; 6(4):367-82.
Park Y, Storkson JM, Albright KJ, Liu W, Pariza MW. Evidence that the trans-10,cis-12 isomer of conjugated linoleic acid induces body composition changes in mice. Lipids.1999; 34(3):235-41.
Atkinson R. Conjugated linoleic acid for altering body composition and treating obesity. In: Yuraweez M, Mossoba M, Kramer J, Pariza M, Nelson G, editors. Advances in conjugated linoleic acid research. Champaign, IL: AOCS Press; 1999. P.353-438.
Zambell KL, Keim NL, Van Loan MD, Gale B, Benito P, Kelley DS, et al. Conjugated linoleic acid supplementation in humans: Effects on body composition and energy expenditure. Lipids. 2000; 35(7):777-82.
Blankson H, Stakkestad JA, Fagertun H, Thom E, Wadstein J, Gudmundsen O. Conjugated linoleic acid reduces body fat mass in overweight and obese humans. J Nutr. 2000; 130(12):2943-8.
Riserus U, Berglund L, Vessby B. Conjugated linoleic acid (CLA) reduced abdominal adipose tissue in obese middle-aged men with signs of the metabolic syndrome: a randomised controlled trial. Int J Obes. 2001; 25(8):1129-35.
Kamphuis MM, Lejeune MP, Saris WH, WesterterpPlantenga MS. The effect of conjugated linoleic acid supplementation after weight loss on body weight regain, body composition, and resting metabolic rate in overweight subjects. Int J Obes. 2003; 27(7):840-7.
Park Y, Pariza MW. Lipoxygenase inhibitors inhibit heparin-releasable lipoprotein lipase activity in 3T3-L1 adipocytes and enhance body fat reduction in mice by conjugated linoleic acid. Biochim Biophys Acta. 2001; 1534(1):27-33.
Bjorntrop P. Visceral obesity: a “civilization syndrome”. Obes Res. 1993; 1(3):206-22.
Ip M, Masso-Welch P, Shoemaker S, Shea-Eaton W. Conjugated linoleic acid inhibits proliferation and induces apoptosis of normal rat mammary epithelial cells in primary culture. Exp Cell Res. 1999; 250(1):22-34.
Brodie A, Manning V, Ferguson K, Jewell D, Hu C. Conjugated linoleic acid inhibits differentiation of pre-and post-confluent 3T3–L1 preadipocytes but inhibits cell proliferation only in preconfluent cells. J Nutr. 1999; 129(3):602-6.
Satory D, Smith S. Conjugated linoleic acid inhibits proliferation but stimulates lipid filling of murine 3T3–L1 preadipocytes. J Nutr.1999; 129(1):92-7.
Miner JL, Cederberg CA, Nielsen MK, Chen X, Baile CA. Conjugated Linoleic Acid (CLA), Body Fat, and Apoptosis. Obes Res. 2001; 9(2):129-34.
Portocarrero C, Bauman D, Barbano D, Zierath J, Houseknecht K. Regulation of UCP1 and UCP2 gene expression by dietary conjugated linoleic acid (CLA) in zucker diabetic fatty (ZDF) rats. In: American Diabetes Association (ADA) annual meeting; 1999 June 17-24; San Diego; 1999. (Abstract – 0021).
Ryder JW, Portocarrero CP, Song XM, Cui L, Yu M, Combatsiaris T, et al. Isomer-Specific Antidiabetic Properties of Conjugated Linoleic Acid: Improved Glucose Tolerance, Skeletal Muscle Insulin Action, and UCP-2 Gene Expression. Diabetes. 2001; 50(5):1149-57.
Rothwell N. Thermogenesis: where are we and where are we going? Report of a workshop held in London 21st April 2001, convened by Professor Mike Stock. Int J Obes. 2001; 25(9):1272-4.
Kawada T. Lipid metabolism related nuclear receptor: the structure, function, expression and classification of peroxisome proliferation-activated receptor (PPAR). Nippon Rinsho. 1998; 56(7): 1722-8.
Moya-Camarena SY, Vanden Heuvel JP, Blanchard SG, Leesnitzer LA, Belury MA. Conjugated linoleic acid is a potent naturally occurring ligand and activator of PPAR alpha. J Lipid Res. 1999; 40(8): 1426-33.
Adams M, Montague CT, Prins JB, Holder JC, Smith As, Sanders L, et al. Activators of peroxisome proliferator-activated receptor gamma have depotspecific effects on human preadipocyte differentiation. J Clin Invest. 1997; 100(12): 3149-53.
Camirand A, Marie V, Rabelo R, Silva J. Thiazolidinediones stimulate uncoupling protein-2 expression in cell lines representing white and brown adipose tissues and skeletal muscle. Endocrinology. 1998; 139(1):428-31.
Riserus U, Smedman A, Basu S, Vessby B. Conjugated Linoleic Acid (CLA) and Body Weight Regulation in Humans. Lipids. 2003; 38(2): 133-37.
Smedman A, Vessby B. Conjugated linoleic acid supplementation in humans-metabolic effects. Lipids. 2001; 36(8):773-81.
Choi Y, Park Y, Pariza M, Ntambi J. Regulation of stearoyl-CoA desaturase activity by the trans-10,cis-12 isomer of conjugated linoleic acid in HepG2 cells. Biochem Biophys Res Commun. 2001; 284(3):689-93.
Downloads
Publicado
Como Citar
Edição
Seção
Licença
Copyright (c) 2023 Denise Machado Mourão, Josefina Bressan Resende MONTEIRO, Neuza Maria Brunoro COSTA, Paulo César STRINGHETA, Valéria Paula Rodrigues MINIM, Cristina Maria Ganns Chaves DIAS
Este trabalho está licenciado sob uma licença Creative Commons Attribution 4.0 International License.
